Similar to TGF-β3 [6], TGF-β1 and TGF-β2 immunoreactivity was detectable in both epithelial and stromal compartments of endometrial tumours (Figure 1A), suggesting that both autocrine and paracrine TGF-β signalling takes place in these tumours. This evidence concerns the gene TGFB1 and neoplasm.